AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32889091 — intervention group
Group type: EXPERIMENTAL
Intervention: CNN algorithm for predicting NAC response
Number of subjects: 131
Study 33478562 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 142
Study 33478562 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture (SEA)
Number of subjects: 142
Study 36108920 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE) - cycling at 70% HRPeak for 30 minutes
Number of subjects: 35
Study 36108920 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (RE) - leg press at 70% RM, jumping for 30 minutes
Number of subjects: 35
Study 36108920 — intervention group
Group type: COMPARATOR
Intervention: Baseline muscle strength (LMQ, handgrip)
Number of subjects: 35
Study 36108920 — intervention group
Group type: COMPARATOR
Intervention: Baseline stair climb power (SCP)
Number of subjects: 35
Study 36108920 — intervention group
Group type: COMPARATOR
Intervention: Baseline physical performance (lower PPT)
Number of subjects: 35
Study 36108920 — intervention group
Group type: COMPARATOR
Intervention: Post-exercise responses
Number of subjects: 35
Study 36108920 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall effect of acute exercise (regardless of mode)
Number of subjects: 35
Study 33458928 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate extract nutraceutical (PE), 320 mg phenolics/day for 1 month
Number of subjects: 50
Study 33458928 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate extract nutraceutical (PE)
Number of subjects: 50
Study 33185527 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical timolol (0.5%) cream, applied three times daily for three months
Number of subjects: 29
Study 33185527 — intervention group
Group type: COMPARATOR
Intervention: Untreated regions
Number of subjects: 29
Study 35296307 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC + pharmacist-managed diabetes clinic (PMDC) group (additional 6 visits with the pharmacist within 6 months)
Number of subjects: 86
Study 35296307 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) group (routine follow up with primary provider)
Number of subjects: 86
Study 35296307 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC + PMDC group
Number of subjects: 86
Study 35296307 — intervention group
Group type: COMPARATOR
Intervention: SOC group
Number of subjects: 86
Study 33685928 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg daily
Number of subjects: 62
Study 33685928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 32729211 — intervention group
Group type: EXPERIMENTAL
Intervention: Humanism and Professionalism curriculum (HP-PHO)
Number of subjects: 100
Study 32729211 — intervention group
Group type: COMPARATOR
Intervention: Usual training in humanism and professionalism (UT)
Number of subjects: 100
Study 35168598 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended version of Necessary Condition Analysis (NCA)
Number of subjects: 533
Study 35168598 — intervention group
Group type: COMPARATOR
Intervention: Original version of Necessary Condition Analysis (NCA)
Number of subjects: 533
Study 34341578 — intervention group
Group type: EXPERIMENTAL
Intervention: Toripalimab plus GP chemotherapy
Number of subjects: 289
Study 34341578 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus GP chemotherapy
Number of subjects: 289
Study 32204978 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin group (receiving 100 mL of orange juice with 12 g of carrot and 2.5 g of turmeric after each dialysis session/week for 3 months)
Number of subjects: 31
Study 32204978 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin group
Number of subjects: 31
Study 32204978 — intervention group
Group type: COMPARATOR
Intervention: Control group (receiving the same juice without curcumin)
Number of subjects: 31
Study 32083522 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g/day of MSM for 16 weeks
Number of subjects: 83
Study 32083522 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g/day of MSM for 16 weeks
Number of subjects: 83
Study 32083522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 34089422 — intervention group
Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 351
Study 34089422 — intervention group
Group type: COMPARATOR
Intervention: Exercise plus diet
Number of subjects: 351
Study 34089422 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 351
Study 34089422 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone, diet alone, and exercise plus diet
Number of subjects: 351
Study 32819439 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus albumin (20 g in 100 mL) every 12 h for 4 days
Number of subjects: 360
Study 32819439 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 360
Study 32819439 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus albumin
Number of subjects: 360
Study 35223910 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal morphine (SM) 0.1 mg
Number of subjects: 114
Study 35223910 — intervention group
Group type: COMPARATOR
Intervention: Bilateral landmark‐oriented TAP block with 20 ml of 0.25% bupivacaine
Number of subjects: 114
Study 34711232 — intervention group
Group type: EXPERIMENTAL
Intervention: umeclidinium/vilanterol 62.5/25 µg once daily
Number of subjects: 2425
Study 34711232 — intervention group
Group type: COMPARATOR
Intervention: umeclidinium 62.5 µg once daily
Number of subjects: 2425
Study 34711232 — intervention group
Group type: COMPARATOR
Intervention: salmeterol 50 µg twice daily
Number of subjects: 2425
Study 33704597 — intervention group
Group type: EXPERIMENTAL
Intervention: Early angiography and revascularization with guideline‐directed medical therapy
Number of subjects: 0
Study 33704597 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 0
Study 34333129 — intervention group
Group type: EXPERIMENTAL
Intervention: Didecyl dimethyl ammonium chloride (DDAC) bathing
Number of subjects: 1540
Study 34333129 — intervention group
Group type: COMPARATOR
Intervention: Regular cleanser/shampoo bathing
Number of subjects: 1540
Study 36254883 — intervention group
Group type: EXPERIMENTAL
Intervention: QMix as final irrigation protocol
Number of subjects: 60
Study 36254883 — intervention group
Group type: COMPARATOR
Intervention: NaOCl as final irrigation protocol
Number of subjects: 60
Study 33900809 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-second video intervention featuring a 22-year-old African American woman with schizophrenia
Number of subjects: 1055
Study 33900809 — intervention group
Group type: EXPERIMENTAL
Intervention: Written vignette intervention containing the same material
Number of subjects: 1055
Study 33900809 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention control condition
Number of subjects: 1055
Study 35971155 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus a personalised and pragmatic resistance exercise intervention for 12 weeks
Number of subjects: 220
Study 35971155 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 220
Study 32789516 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg D-Cycloserine (DCS)
Number of subjects: 163
Study 32789516 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg D-Cycloserine (DCS)
Number of subjects: 163
Study 32789516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study 33783470 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of oral atomoxetine
Number of subjects: 19
Study 33783470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 33783470 — intervention group
Group type: COMPARATOR
Intervention: Control group (26 subjects)
Number of subjects: 19
Study 32424445 — intervention group
Group type: COMPARATOR
Intervention: Staples
Number of subjects: 62
Study 32424445 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcuticular suture
Number of subjects: 62
Study 36064383 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal chiropractic care
Number of subjects: 21
Study 34487919 — intervention group
Group type: EXPERIMENTAL
Intervention: Carrageenan-containing gel
Number of subjects: 0
Study 34487919 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 0
Study 36125103 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous bleaching with 10% hydrogen peroxide for 2 weeks
Number of subjects: 100
Study 36125103 — intervention group
Group type: COMPARATOR
Intervention: Single arch bleaching with 10% hydrogen peroxide for 4 weeks
Number of subjects: 100
Study 33349055 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment-Based Family Therapy (ABFT)
Number of subjects: 60
Study 33349055 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 60
Study 34254449 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LS)
Number of subjects: 52
Study 34254449 — intervention group
Group type: COMPARATOR
Intervention: Open surgery (OS)
Number of subjects: 52
Study 34155082 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fat‐based energy‐dense supplement (300 kcal daily) for 12 weeks
Number of subjects: 240
Study 34155082 — intervention group
Group type: COMPARATOR
Intervention: Routine care for 12 weeks
Number of subjects: 240
Study 34273598 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI 300 cGy
Number of subjects: 179
Study 34273598 — intervention group
Group type: COMPARATOR
Intervention: TBI 200 cGy
Number of subjects: 179
Study 32663699 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity scheduling (experimental group, n=50)
Number of subjects: 100
Study 32663699 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=50)
Number of subjects: 100
Study 36123011 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg once daily for 24 months
Number of subjects: 5112
Study 36123011 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg once daily for 24 months
Number of subjects: 5112
Study 36123011 — intervention group
Group type: COMPARATOR
Intervention: Underweight category
Number of subjects: 5112
Study 36123011 — intervention group
Group type: COMPARATOR
Intervention: Normal weight category
Number of subjects: 5112
Study 34318392 — intervention group
Group type: EXPERIMENTAL
Intervention: #Tamojunto program
Number of subjects: 6391
Study 33072352 — intervention group
Group type: EXPERIMENTAL
Intervention: Telegram-based education
Number of subjects: 64
Study 33072352 — intervention group
Group type: COMPARATOR
Intervention: In-person education
Number of subjects: 64
Study 616388350 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine/atorvastatin (Group 3)
Number of subjects: 144
Study 616388350 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (Group 2)
Number of subjects: 144
Study 616388350 — intervention group
Group type: COMPARATOR
Intervention: Hypotensor alone (Group 1)
Number of subjects: 144
Study 35889926 — intervention group
Group type: EXPERIMENTAL
Intervention: Mo-enriched lettuce
Number of subjects: 24
Study 35889926 — intervention group
Group type: COMPARATOR
Intervention: Control group (lettuce)
Number of subjects: 24
Study 34380344 — intervention group
Group type: EXPERIMENTAL
Intervention: Wii Fit Plus games
Number of subjects: 54
Study 34380344 — intervention group
Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 54
Study 32376818 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin treatment
Number of subjects: 79
Study 32376818 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 79
Study 35491577 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor balancing (SB)
Number of subjects: 250
Study 35491577 — intervention group
Group type: COMPARATOR
Intervention: Manual balancing (MB)
Number of subjects: 250
Study 35491577 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 250
Study 34721416 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group (Lactobacillus plantarum CCFM1143)
Number of subjects: 55
Study 34721416 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 55
Study 34069479 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontitis (genetic liability)
Number of subjects: 2215
Study 34069479 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontitis (validation SNPs)
Number of subjects: 2215
Study 34069479 — intervention group
Group type: EXPERIMENTAL
Intervention: Parkinson’s disease (genetic liability)
Number of subjects: 2215
Study 33353921 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine-Ketorolac (Li-KT)
Number of subjects: 88
Study 33353921 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine-Saline (Li-Saline)
Number of subjects: 88
Study 33353921 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Li-KT and Li-Saline)
Number of subjects: 88
Study 35263421 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper Intrauterine Device (Cu-IUD)
Number of subjects: 251
Study 35263421 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot Medroxyprogesterone Acetate (DMPA-IM)
Number of subjects: 251
Study 35263421 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel Implant (LNG-implant)
Number of subjects: 251
Study 35263421 — intervention group
Group type: COMPARATOR
Intervention: HIV cases (n = 25)
Number of subjects: 251
Study 35263421 — intervention group
Group type: COMPARATOR
Intervention: HIV controls (n = 100)
Number of subjects: 251
Study 33689452 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Group (VRG) - virtual reality exercise (volleyball, Microsoft Xbox Kinect®, 3 days per week, 15 minutes per day) and cycling exercise for 4 weeks
Number of subjects: 40
Study 33689452 — intervention group
Group type: COMPARATOR
Intervention: Conventional Training Group (CTG) - aerobic exercise (cycling, 3 days per week, 20 minutes per day) and conventional exercises (muscle strengthening, balance, and flexibility, 3 days per week, 15 minutes per day) for 4 weeks
Number of subjects: 40
Study 32301885 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 431
Study 32301885 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral access (TFA)
Number of subjects: 431
Study 35325457 — intervention group
Group type: EXPERIMENTAL
Intervention: No accompanying person (March 2020)
Number of subjects: 872
Study 35325457 — intervention group
Group type: COMPARATOR
Intervention: Control group 2 (February 2020)
Number of subjects: 872
Study 35325457 — intervention group
Group type: COMPARATOR
Intervention: Control group 3 (March 2019)
Number of subjects: 872
Study 34389579 — intervention group
Group type: EXPERIMENTAL
Intervention: CIME model (Community-delivered Integrated Malaria Elimination)
Number of subjects: 140
Study 34389579 — intervention group
Group type: COMPARATOR
Intervention: ICMV (current model of care)
Number of subjects: 140
Study 32779269 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0
Study 34111874 — intervention group
Group type: EXPERIMENTAL
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP)
Number of subjects: 291
Study 34111874 — intervention group
Group type: COMPARATOR
Intervention: Diagnosis-specific cognitive behavioral therapy (dCBT)
Number of subjects: 291
Study 33291974 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth Readiness Intervention (YRI)
Number of subjects: 175
Study 32064971 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-cycle regimen of combined oral contraceptive (ethinylestradiol 30μg and levonorgestrel 150μg)
Number of subjects: 1314
Study 32064971 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-cycle regimen
Number of subjects: 1314
Study 32064971 — intervention group
Group type: COMPARATOR
Intervention: Conventional-cycle regimen
Number of subjects: 1314
Study 32064971 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 1314
Study 37142540 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 100 U/mL (IGlar‐100)
Number of subjects: 2684
Study 34404293 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-second ISI
Number of subjects: 30
Study 34404293 — intervention group
Group type: EXPERIMENTAL
Intervention: Supra-second ISI
Number of subjects: 30
Study 34404293 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency tones in supra-second ISI
Number of subjects: 30
Study 34404293 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency tones in supra-second ISI
Number of subjects: 30
Study 34077057 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on the Health Belief Model (HBM)
Number of subjects: 164
Study 34077057 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 164
Study 34021510 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise and health counselling
Number of subjects: 70
Study 34021510 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 70
Study 32361332 — intervention group
Group type: EXPERIMENTAL
Intervention: Raman spectroscopy followed by chemometrics
Number of subjects: 0
Study 35441666 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)
Number of subjects: 72
Study 35441666 — intervention group
Group type: COMPARATOR
Intervention: Befriending therapy
Number of subjects: 72
Study 32468855 — intervention group
Group type: EXPERIMENTAL
Intervention: SPARK Precision
Number of subjects: 83
Study 32468855 — intervention group
Group type: COMPARATOR
Intervention: SITA Standard
Number of subjects: 83
Study 32723555 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI) using Evolut R device
Number of subjects: 290
Study 35394462 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-guided balancing device
Number of subjects: 130
Study 35394462 — intervention group
Group type: COMPARATOR
Intervention: Freehand balancing technique
Number of subjects: 130
Study 32652528 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg every 2 weeks (q2w)
Number of subjects: 772
Study 32652528 — intervention group
Group type: COMPARATOR
Intervention: Secukinumab 300 mg every 4 weeks (q4w)
Number of subjects: 772
Study 35258595 — intervention group
Group type: EXPERIMENTAL
Intervention: PnM + IStrSR group (perineal massage + instrument-assisted perineal stretching with short repeated protocol)
Number of subjects: 96
Study 35258595 — intervention group
Group type: EXPERIMENTAL
Intervention: PnM group (perineal massage)
Number of subjects: 96
Study 35258595 — intervention group
Group type: EXPERIMENTAL
Intervention: PnM + IStrLS group (perineal massage + instrument-assisted perineal stretching with long static protocol)
Number of subjects: 96
Study 35258595 — intervention group
Group type: COMPARATOR
Intervention: IStrLS group (instrument-assisted perineal stretching with long static protocol)
Number of subjects: 96
Study 33105246 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB) with 10ml of ropivacaine 1.0%
Number of subjects: 48
Study 33105246 — intervention group
Group type: COMPARATOR
Intervention: Interscalene brachial plexus block (ISB) with 10ml of ropivacaine 1.0%
Number of subjects: 48
Study 33105246 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB)
Number of subjects: 48
Study 33105246 — intervention group
Group type: COMPARATOR
Intervention: Interscalene brachial plexus block (ISB)
Number of subjects: 48
Study 33105246 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study 33252406 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention delivered by trained Lay Health Advisors
Number of subjects: 0
Study 33252406 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34682331 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional Guidance and Training Group (NTG)
Number of subjects: 98
Study 34682331 — intervention group
Group type: COMPARATOR
Intervention: Training Group (TG)
Number of subjects: 98
Study 32184313 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral melatonin (Circadin) 2 mg at night for 6 weeks
Number of subjects: 60
Study 32184313 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32879998 — intervention group
Group type: EXPERIMENTAL
Intervention: Cysteamine 5% cream
Number of subjects: 54
Study 32879998 — intervention group
Group type: COMPARATOR
Intervention: Tranexamic Acid (TA) mesotherapy
Number of subjects: 54
Study 32861897 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 320
Study 32861897 — intervention group
Group type: COMPARATOR
Intervention: Patient education
Number of subjects: 320
Study 33118052 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayahuasca (single dose)
Number of subjects: 17
Study 32901672 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral aprepitant (80 mg), intravenous dexamethasone (8 mg), and palonosetron (0.075 mg)
Number of subjects: 100
Study 32901672 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo, intravenous dexamethasone (4 mg), and palonosetron (0.075 mg)
Number of subjects: 100
Study 35025993 — intervention group
Group type: EXPERIMENTAL
Intervention: Olezarsen 10 mg every 4 weeks
Number of subjects: 114
Study 35025993 — intervention group
Group type: EXPERIMENTAL
Intervention: Olezarsen 15 mg every 2 weeks
Number of subjects: 114
Study 35025993 — intervention group
Group type: EXPERIMENTAL
Intervention: Olezarsen 10 mg every week
Number of subjects: 114
Study 35025993 — intervention group
Group type: EXPERIMENTAL
Intervention: Olezarsen 50 mg every 4 weeks
Number of subjects: 114
Study 35025993 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 114
Study 34371824 — intervention group
Group type: EXPERIMENTAL
Intervention: Crocodile blood supplementation (CB) - 1 g day−1 for 18 days
Number of subjects: 16
Study 34371824 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 16
Study 36017797 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine tablets (3.5 mg/kg)
Number of subjects: 968
Study 36017797 — intervention group
Group type: COMPARATOR
Intervention: Placebo (after cladribine tablets)
Number of subjects: 968
Study 33355258 — intervention group
Group type: EXPERIMENTAL
Intervention: Control-IQ closed-loop control (CLC) system
Number of subjects: 101
Study 33355258 — intervention group
Group type: COMPARATOR
Intervention: Sensor-augmented pump (SAP) therapy
Number of subjects: 101